Filing Details
- Accession Number:
- 0001209191-18-039404
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-25 16:31:35
- Reporting Period:
- 2018-06-21
- Accepted Time:
- 2018-06-25 16:31:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
860730 | Hca Healthcare Inc. | HCA | Services-General Medical & Surgical Hospitals, Nec (8062) | 273865930 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1373493 | B Jonathan Perlin | One Park Plaza Nashville TN 37203 | Pres-Clinical Services & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-06-21 | 12,500 | $21.35 | 107,894 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-06-21 | 12,500 | $108.00 | 95,394 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-06-21 | 12,500 | $0.00 | 12,500 | $21.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-11-02 | 2021-11-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 913 | Indirect | By 2011 GRAT, Reporting Person Trustee |
Common Stock | 3,846 | Indirect | By 2012 GRAT, Reporting Person Trustee |
Footnotes
- The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.